Profil
Kim Raineri worked as a Business Director at Lonza Bioscience Singapore Pte Ltd. He was a Senior Manager at Artivion, Inc. from 1999 to 2005.
From 2016 to 2020, he served as Vice President of Operations at Nikon CeLL innovation Co., Ltd. In 2020, he became the Chief Manufacturing & Technical Operations Officer at Avrobio, Inc. Mr. Raineri holds an MBA from Kennesaw State University and an undergraduate degree from the University of Miami.
Anciens postes connus de Kim Raineri
| Sociétés | Poste | Fin |
|---|---|---|
| TECTONIC THERAPEUTIC, INC. | Directeur Technique/Scientifique/R&D | 01/07/2022 |
Nikon CeLL innovation Co., Ltd. | Corporate Officer/Principal | 01/06/2020 |
| ARTIVION, INC. | Corporate Officer/Principal | 01/01/2005 |
Lonza Bioscience Singapore Pte Ltd.
Lonza Bioscience Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formation de Kim Raineri
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Artivion, Inc.
Artivion, Inc. Medical SpecialtiesHealth Technology Provides cryopreserved human tissue for vascular transplant applications | Health Technology |
Kennesaw State University
Kennesaw State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVROBIO, Inc.
AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
Lonza Bioscience Singapore Pte Ltd.
Lonza Bioscience Singapore Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nikon CeLL innovation Co., Ltd. |
















